Diagnosis and management of hypertension: around-the-clock ambulatory blood pressure monitoring is substantially more effective and less costly than daytime office blood pressure measurements

References

• [NICE] National Institute for Health and Clinical Excellence. 2011. Hypertension: the clinical management of primary hypertension in adults. NICE Clinical Guidelines 127: Methods, evidence and recommendations. National Clinical Guidelines Centre, London (UK). [accessed 2019 July 23]. http://guidance.nice.org.uk/CG/Wave2/14.
   Google Scholar
• Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al. 2019. Heart disease and stroke statistics-2019 update: A report from the American Heart Association. Circulation. 139:e56–e528.
   PubMed Web of Science ®Google Scholar
• Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen CH, et al. 2007. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 370:1219–1229.
   PubMed Web of Science ®Google Scholar
• Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, et al. 2003. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 348:2407–2415.
   PubMed Web of Science ®Google Scholar
• Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E. 2005. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 46:156–161.
   PubMed Web of Science ®Google Scholar
• Ewald B, Pekarsky B. 2002. Cost analysis of ambulatory blood pressure monitoring in initiating antihypertensive drug treatment in Austrilian general practice. Med J Aust. 176:580–583.
   PubMed Web of Science ®Google Scholar
• Hermida RC. 2016. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: rationale and design of the Hygia project. Chronobiol Int. 33:906–936.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, Fernández JR. 2013a. Influence of age and hypertension treatment-time on ambulatory blood presure in hypertensive patients. Chronobiol Int. 30:176–191.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. 2013b. Ambulatory blood pressure monitoring: importance of sampling rate and duration – 48 versus 24 hours – on the accurate assessment of cardiovascular risk. Chronobiol Int. 30:55–67.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2011. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 58:1165–1173.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2012. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension. Am J Hypertens. 25:297–305.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2013c. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level – The “normotensive non-dipper” paradox. Chronobiol Int. 30:87–98.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2016. Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention. Diabetologia. 59:244–254.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Ayala DE, Mojón A, Fernández JR. 2017. Sleep-time ambulatory BP is an independent prognostic marker of CKD. J Am Soc Nephrol. 28:2802–2811.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Crespo JJ, Otero A, Domínguez-Sardiña M, Moyá A, Ríos MT, Castiñeira MC, Callejas PA, Pousa L, Sineiro E, et al. 2018. Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention. Eur Heart J. 39:4159–4171.
   PubMed Web of Science ®Google Scholar
• Hermida RC, Smolensky MH, Ayala DE, Portaluppi F, Crespo JJ, Fabbian F, Haus E, Manfredini R, Mojón A, Moyá A, et al. 2013d. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Joint recommendations from the International Society for Chronobiology (ISC), American association of medical chronobiology and chronotherapeutics (AAMCC), Spanish society of applied chronobiology, chronotherapy, and vascular risk (SECAC), Spanish society of atherosclerosis (SEA), and Romanian society of internal medicine (RSIM). Chronobiol Int. 30:355–410.
   PubMed Web of Science ®Google Scholar
• Imai Y. 1995. Clinical significance and cost-effectiveness of 24-hour ambulatory blood pressure monitoring. Tohoku J Exp Med. 176:1–15.
   PubMed Web of Science ®Google Scholar
• Krakoff LR. 2006. Cost-effectiveness of ambulatory blood pressure: A reanalysis. Hypertension. 47:29–34.
   PubMed Web of Science ®Google Scholar
• Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M. 2006. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J. 27:1610–1619.
   PubMed Web of Science ®Google Scholar
• Llisterri JL, Rodriguez-Roca GC, Escobar C, Alonso-Moreno FJ, Prieto MA, Barrios V, González-Alsina D, Divisón JA, Pallarés V, Beato P. 2012. Treatment and blood pressure control in Spain during 2002–2010. J Hypertens. 30:2425–2431.
   PubMed Web of Science ®Google Scholar
• Lorgelly P, Siatis I, Brooks A, Slinn B, Millar-Craig MW, Donnelly R, Manning G. 2003. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care? Br J Med Pract. 53:794–796.
   PubMed Web of Science ®Google Scholar
• Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, Hodgkinson J, Mant J, Martin U, Williams B, et al. 2011. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 378:1219–1230.
   PubMed Web of Science ®Google Scholar
• Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboni P, Conte G, Gabbai FB, et al. 2011. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 171:1090–1098.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, et al. 2002. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Otero A, de Francisco ALM, Gayoso P, García F; on behalf of the EPIRCE Study Group. 2010. Prevalence of chronic kidney disease in Spain: results of the EPIRCE study. Nefrología 30:78–86.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Cuccurullo F. 2011. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: An updated meta-analysis. Am J Hypertens. 24:52–58.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Mezzetti A, Lapenna D, Guglielmi MD, Mancini M, Salvatore L, Antidormi T, Costantini F, Cuccurullo F. 1995. ‘White-coat’ hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J. 16:692–697.
   PubMed Web of Science ®Google Scholar
• Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. 2015. Diagnosis and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive services task force. Ann Intern Med. 162:192–204.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roca GC, Alonso-Moreno FJ, Garcia-Jimenez A, Hidalgo-Vega A, Llisterri-Caro JL, Barrios-Alonso V, Segura-Fragoso A, Clemente-Lirola E, Estepa-Jorge S, Delgado-Cejudo Y, et al. 2006. Cost-effectiveness of ambulatory blood pressure monitoring in the follow-up of hypertension. Blood Press. 15:27–36.
   PubMed Web of Science ®Google Scholar
• Roush GC, Fagard RH, Salles GF, Pierdomenico SD, Reboldi G, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2014. Prognostic impact from clinic, daytime, and nighttime systolic blood pressure in 9 cohorts on 13,844 patients with hypertension. J Hypertens. 32:2332–2340. doi:10.1097/HJH.0000000000000355.
   PubMed Web of Science ®Google Scholar
• Salles GF, Reboldi G, Fagard RH, Cardoso C, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, et al. 2016. Prognostic impact of the nocturnal blood pressure fall in hypertensive patients: The ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 67:693–700.
   PubMed Web of Science ®Google Scholar
• Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, Casamitjana R, Castaño L, Castell C, Catalá M, et al. 2012. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the diabet.es study. Diabetologia. 55:88–93.
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmerfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2018. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 71:e127–e248.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018. 2018 ESC/EHS guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH). Eur Heart J. 39:3021–3104.
   PubMed Web of Science ®Google Scholar